NCT05724121
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
StatusActive, Not Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
The 50 most recent of 125 versions: 2 with changes below, 48 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Minor Enrollment closed, study ongoing
- Final enrollment: 75 participants (planned 135)
- Site details revised
- Notable Eligibility criteria expanded, about 7 words
- Study description expanded, about 15 words
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
arrhythmogenic cardiac effects of BTKi and sudden death within the first 12 months of BTKi therapy
Timeframe: 12 months
Secondary (1)
tests for identifying and monitoring cardiac arrhythmias in patients receiving BTKi
Arms and interventions
Cohort A
includes all patients prior to starting therapy with a BTKi
Cohort B
includes all patients already on therapy with a BTKi
Cohort C
includes all patients prior to starting therapy with venetoclax
Sites
1 site in 1 country
- National Institutes of Health Clinical CenterBethesda, Maryland, United States